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   Abstract 
Aims   
Chronically elevated inflammation provides a putative target in the search of a meaningful 
biomarker for chronic fatigue syndrome (CFS).  While research has investigated levels of 
inflammatory biomarkers in people with CFS compared with healthy controls, these groups have not 
yet been examined at a meta-analytic level. To evaluate the degree and direction of these 
associations, we identified the existing evidence and combined these. 
Methods 
A systematic review sought studies that compared levels of inflammatory proteins in people with a 
diagnosis of CFS. Using data from the included studies, meta-analyses compared levels of biomarkers 
measured in at least four studies.  
Results 
48 studies were included following the systematic search, and thirteen biomarkers were examined in 
analyses. Tumor necrosis factor-alpha (TNFa), transforming growth factor-beta (TGFb), c-reactive 
protein (CRP), interleukins 2 (IL-2), 4 (IL-4), 1-beta (IL-1b) and 12 (IL-12) were elevated in people with 
CFS compared to controls; the remaining biomarkers (IFNy, IL-1a, IFNa, IL-8, IL-10 and IL-6) were not 
different between the two populations. 
Conclusions 
It is not possible at this stage to elucidate whether high inflammation in CFS is of primary 
pathophysiological importance or secondary to other factors (e.g. stressful experiences, sleep 
disturbances, physical deconditioning, endocrinological changes), and the role of inflammatory 
alterations in treatment is not addressed by these analyses. However, these results have potentially 
important implications for the understanding, classification and treatment for CFS, pending further 
investigations of inflammatory mechanisms. 
